Cel Sci (CVM) Change in Inventory (2010 - 2024)
Cel Sci (CVM) posted Change in Inventory of -$131489.0 for Q3 2024, down 305.36% sequentially from $64030.0 in Q2 2024, and down 199.44% YoY from $132236.0 in Q4 2023.
Cel Sci (CVM) Change in Inventory (2010 - 2024) Analysis & Trends
Cel Sci has reported Change in Inventory for 14 years, with the latest figure at -$131489.0 in Q3 2024.
- Quarterly Change in Inventory fell 199.44% year-over-year to -$131489.0 in Q3 2024, while the trailing twelve-month figure through Sep 2024 was $172608.0 (up 10.13% YoY) and the FY2024 annual result came in at $172608.0, up 10.13% from the prior year.
- Change in Inventory eased to -$131489.0 in Q3 2024 per CVM's latest filing, from $64030.0 in the prior quarter.
- Over five years, Change in Inventory peaked at $427339.0 in Q3 2021 and troughed at -$325883.0 in Q3 2022.
- A 5-year average of $26110.4 and a median of $3851.5 in 2020 frame the typical range for Change in Inventory.
- The sharpest annual moves came in 2022 and 2023: Change in Inventory plunged 247.87% in 2022, then soared 146.44% in 2023.
- Over 5 years, Change in Inventory stood at -$56327.0 in 2020, then declined by 8.54% to -$61139.0 in 2021, then slumped by 247.87% to -$212687.0 in 2022, then jumped by 146.44% to $98765.0 in 2023, then slumped by 233.13% to -$131489.0 in 2024.
- According to Business Quant data, Change in Inventory over the past three periods registered -$131489.0, $64030.0, and $141302.0 for Q3 2024, Q2 2024, and Q1 2024 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 27.70 Mn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 28.20 Mn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 132.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 47.15 Mn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | -280,000.00 |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 12.97 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 135.26 Mn |
| 10 | Cel Sci | 2.16 Mn | -4.37 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | -131,489.00 |
| Sep 30, 2024 | -131,489.00 |
| Jun 30, 2024 | 64,030.00 |
| Jun 30, 2024 | 64,030.00 |
| Mar 31, 2024 | 141,302.00 |
| Mar 31, 2024 | 141,302.00 |
| Dec 31, 2023 | 98,765.00 |
| Dec 31, 2023 | 98,765.00 |
| Sep 30, 2023 | 132,236.00 |
| Sep 30, 2023 | 132,236.00 |
| Jun 30, 2023 | -145,943.00 |
| Jun 30, 2023 | -145,943.00 |
| Mar 31, 2023 | 383,121.00 |
| Mar 31, 2023 | 383,121.00 |
| Dec 31, 2022 | -212,687.00 |
| Dec 31, 2022 | -212,687.00 |
| Sep 30, 2022 | -325,883.00 |
| Sep 30, 2022 | -325,883.00 |
| Dec 31, 2021 | -61,139.00 |
| Dec 31, 2021 | -61,139.00 |